Robert de JongAssociate Director Antibody Research & Technology at Genmab
Dr. Rob de Jong has worked in different roles at Genmab since 2007, spanning a.o. molecular biology, CMC-supportive research, and protein engineering and is an inventor of Genmab’s HexaBody® and HexElect® technologies. He currently leads Genmab’s Antibody Format Development efforts, aimed at translating biomolecular and structural insights into novel therapeutic antibody platform technologies.